bioRxiv · 10.1101/2023.11.12.566739
A synthetic CRISPR-Cas nuclease with expanded enzymatic activities
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated endonucleases have revolutionized biotechnology for their potential as programmable genome editors. Yet, most natural nucleases and their variants have limitations. Here, we report a fully synthetic CRISPR-associated (Cas) nuclease (-synCas) designed by Ancestral Sequence Reconstruction (ASR) that displays a set of robust and distinct targeting properties, not found in any other known CRISPR-Cas Class 2 system. We show that -synCas is a PAMless nuclease able to catalyse RNA-guided, specific cleavage of dsDNA, ssDNA and ssRNA. The synthetic enzyme is also capable of sequence-nonspecific degradation of dsDNA, ssDNA and ssRNA following activation by complementary dsDNA, ssDNA and ssRNA targets. Furthermore, -synCas exhibits a robust genome editing activity in human cells and bacteria. Cryo-electron microscopy structures of -synCas ternary and quaternary complexes provide a framework to understand the structural basis for its expanded enzymatic activities. The capability for programmable multimodal targeting of virtually any nucleic acid sequence distinguishes -synCas as a promising new tool to extend current CRISPR-based technologies.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jabalera, Y., Tascon, I., Samperio, S., Lopez-Alonso, J. P., Gonzalez-Lopez, M., Aransay, A. M., Abascal-Palacios, G., Ubarretxena-Belandia, I., Perez-Jimenez, R.. 2023-11-12. A synthetic CRISPR-Cas nuclease with expanded enzymatic activities. https://doi.org/10.1101/2023.11.12.566739
Cite the original work for its findings. Save a collection to share your selection of sources.